EcoDrugPlus

Ensembl ID : ENSODEG00000011316
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSODEG00000000121
Gene Symbol: -
Cross references: -
219 Possible Orthologues:

Ensembl ID : ENSODEG00000000138
Gene Symbol: -
Cross references: -
219 Possible Orthologues:

Ensembl ID : ENSODEG00000003742
Gene Symbol: -
Cross references: -
125 Possible Orthologues:

Ensembl ID : ENSODEG00000001789
Gene Symbol: -
Cross references: -
125 Possible Orthologues:

Ensembl ID : ENSODEG00000001305
Gene Symbol: -
Cross references: -
125 Possible Orthologues:

Ensembl ID : ENSODEG00000000548
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSODEG00000017102
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSODEG00000013852
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSODEG00000001486
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSODEG00000020536
Gene Symbol: -
Cross references: -
20 Possible Orthologues:

Ensembl ID : ENSODEG00000007323
Gene Symbol: -
Cross references: -
119 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).